Bayer (BAYN GY) announces that results from the Phase III FIND-CKD trial investigating KERENDIA in adults with nd-CKD met the primary endpoint by showing a significant reduction in the rate of kidney disease progression

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Lebanon's Parliament Speaker says he would agree to Hezbollah withdrawal from southern Lebanon in parallel with an Israeli withdrawal

Brazil's tax revenue secretary said Brazil will be working with US tax authorities to intensify cooperation agreements, via O Globo

Bayer (BAYN GY) announces that results from the Phase III FIND-CKD trial investigating KERENDIA in adults with nd-CKD met the primary endpoint by showing a significant reduction in the rate of kidney disease progression

Lebanese army reinforcements have been deployed after a clash between Hezbollah and Amal members is Bisariyeh, Al Hadath reports

Indian Fiscal Year GDP Growth 3rd Est (2025-26) 7.7% (Prev. 7.1%)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free